Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Biotech Manufacturers to Develop Better Nucleic Acid Sample Preparation Protocols

By LabMedica International staff writers
Posted on 02 Nov 2014
Manufacturers of biotech equipment and reagents are cooperating to ease and simplify protocols for preparing samples to be analyzed by advanced next generation sequencing platforms.

The success of techniques such as next-generation sequencing, microarrays, and library construction is contingent upon the precise and accurate processing of DNA and RNA. More...
Library preparation of nucleic acids relies on a coordinated series of standard molecular biology reactions, and preparation of high quality libraries at high yield is a critical first step in the next generation sequencing workflow. The necessity for improved reagents and protocols for library preparation is growing in parallel with the increase in the number of applications for next generation sequencing.

To develop these new protocols, the instrument manufacturer Beckman Coulter Life Sciences (Nyon, Switzerland) will be collaborating with the reagent manufacturer New England Biolabs, Inc. (Ipswich, MA, USA). Beckman Coulter produces advanced automated liquid handling systems such as the Biomek 4000. New England Biolabs manufactures a line of highly pure "NEBNext" reagents that facilitate library preparation of DNA or RNA for downstream applications such as next generation sequencing and expression library construction.

It is planned that Beckman Coulter will use its extensive experience in automated next generation sequencing sample preparation to develop, distribute, and support automation for New England Biolabs' NEBNext sample preparation reagent kits. New England Biolabs will provide technical expertise on the reagents, chemistry, and protocols.

“Beckman Coulter’s focus on providing our next generation sequencing customers a top-notch portfolio of automated sample preparation solutions makes a partnership with New England Biolabs, a world leading provider of quality reagent systems for molecular biology research, a natural fit,” said Alisa Jackson, senior marketing manager, automated genomics solutions at Beckman Coulter. “Our joint collaborations with scientific researchers have already led to the development of high-quality methods demonstrated to improve efficiency, throughput and results for some of the most challenging sample inputs.”

Related Links:

Beckman Coulter Life Sciences
New England Biolabs, Inc.



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.